Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: August 4, 2026
Reporting Period: Single event date (August 4, 2026)
Business Context: The filing serves as a Regulation FD disclosure to announce upcoming investor and analyst presentations. The company intends to utilize the material contained in Exhibit 99.1 (Investor Presentation dated August 2026) for these communications.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose the existence of an investor presentation rather than a financial report containing audited or unaudited financial statements.
Material Changes
No material changes to financial performance or operations are reported in this specific filing text. The document solely references the distribution of presentation materials to the investment community.
Guidance, Outlook, and Risks
- Management Commentary: Executive officers are scheduled to present to investors and analysts using the attached Exhibit 99.1.
- Legal Status of Information: The information furnished under Item 7.01, including the referenced Exhibit 99.1, is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
- Risks and Contingencies: No specific risks or contingencies are detailed in the body of this 8-K filing.
Investor Verification Checklist
- Review Exhibit 99.1 (OrthoPediatrics Corp. Investor Presentation dated August 2026) for actual financial data, guidance, and strategic outlook, as this 8-K only announces its existence.
- Verify the date and content of the upcoming investor presentations mentioned by executive officers.
- Confirm that the information in the presentation is not automatically incorporated by reference into other SEC filings per the disclaimer in Item 7.01.